At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
MBOT Microbot Medical Inc
Market Closed 12-05 16:00:00 EST
2.37
-0.09
-3.66%
盘后2.39
+0.02+0.84%
19:55 EST
High2.53Low2.33Vol3.03M
Open2.49D1 Closing2.46Amplitude8.33%
Mkt Cap159.16MTradable Cap159.16MTotal Shares67.16M
T/O7.30MT/O Rate4.51%Tradable Shares67.16M
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--

Loading ...

After AI Push, Trump Administration Is Now Looking to Robots
Tiger Newspress  ·  12-03
After AI Push, Trump Administration Is Now Looking to Robots
Microbot Medical Initiated at Buy by Roth Capital
Dow Jones  ·  12-04 02:08
Microbot Medical Initiated at Buy by Roth Capital
Microbot Medical Price Target Maintained With a $12.00/Share by HC Wainwright & Co.
Dow Jones  ·  11-28
Microbot Medical Price Target Maintained With a $12.00/Share by HC Wainwright & Co.
Sector Update: Health Care Stocks Mixed in Afternoon Trading
MT Newswires Live  ·  11-27
Sector Update: Health Care Stocks Mixed in Afternoon Trading
Emory University Hospital Adopts Microbot Medical's LIBERTY Endovascular Robotic System
Reuters  ·  11-26
Emory University Hospital Adopts Microbot Medical's LIBERTY Endovascular Robotic System
Microbot Medical Inc expected to post a loss of 6 cents a share - Earnings Preview
Reuters  ·  11-08
Microbot Medical Inc expected to post a loss of 6 cents a share - Earnings Preview
Microbot Medical- Launches Limited Market Release of Liberty® Endovascular Robotic System in US
THOMSON REUTERS  ·  11-05
Microbot Medical- Launches Limited Market Release of Liberty® Endovascular Robotic System in US
Microbot Medical Inc - Full Market Release Expected at Sir Conference in April 2026
THOMSON REUTERS  ·  11-05
Microbot Medical Inc - Full Market Release Expected at Sir Conference in April 2026
Microbot Medical Launches LIBERTY Robotic System in U.S. Market
Reuters  ·  11-05
Microbot Medical Launches LIBERTY Robotic System in U.S. Market
Microbot Medical Inc. Receives FDA 510(k) Clearance for LIBERTY® Endovascular Robotic System, Prepares for Q4 Commercial Launch
Reuters  ·  10-16
Microbot Medical Inc. Receives FDA 510(k) Clearance for LIBERTY® Endovascular Robotic System, Prepares for Q4 Commercial Launch
Microbot Medical Price Target Maintained With a $12.00/Share by HC Wainwright & Co.
Dow Jones  ·  10-15
Microbot Medical Price Target Maintained With a $12.00/Share by HC Wainwright & Co.
Microbot Medical announces partnership with US logistics provider to support Liberty System commercialization
Reuters  ·  10-14
Microbot Medical announces partnership with US logistics provider to support Liberty System commercialization
BRIEF-Microbot Medical Inc Files For Offering Of Up To 14.7 Million Shares Of Common Stock By The Selling Stockholders - SEC Filing
Reuters  ·  10-14
BRIEF-Microbot Medical Inc Files For Offering Of Up To 14.7 Million Shares Of Common Stock By The Selling Stockholders - SEC Filing
Microbot Medical Inc Files for Offering of up to 14.7 Mln Shares of Common Stock by the Selling Stockholders - SEC Filing
THOMSON REUTERS  ·  10-14
Microbot Medical Inc Files for Offering of up to 14.7 Mln Shares of Common Stock by the Selling Stockholders - SEC Filing
Microbot Medical closes exercise of outstanding preferred investment options
TIPRANKS  ·  10-07
Microbot Medical closes exercise of outstanding preferred investment options
Microbot Medical Announces $29.2 Million in Gross Proceeds from Private Placement, with Potential for Additional $63 Million Through New Series J Preferred Investment Options
Reuters  ·  10-07
Microbot Medical Announces $29.2 Million in Gross Proceeds from Private Placement, with Potential for Additional $63 Million Through New Series J Preferred Investment Options
Microbot Medical Inc. Issues 600,000 Shares, 374,167 Shares in Preferred Option Exercises, and Grants New Series J Options in Recent Transactions
Reuters  ·  10-04
Microbot Medical Inc. Issues 600,000 Shares, 374,167 Shares in Preferred Option Exercises, and Grants New Series J Options in Recent Transactions
Microbot Medical Inc - Receives First Patent in Japan for Liberty System - SEC Filing
THOMSON REUTERS  ·  10-01
Microbot Medical Inc - Receives First Patent in Japan for Liberty System - SEC Filing
Microbot Medical Secures First Japanese Patent for LIBERTY® Endovascular Robotic System, Expanding Global IP Portfolio
Reuters  ·  10-01
Microbot Medical Secures First Japanese Patent for LIBERTY® Endovascular Robotic System, Expanding Global IP Portfolio
Microbot Medical Inc. Announces Special One-Time Cash Bonuses and Amended Compensation for Executives and Non-Management Board Members
Reuters  ·  09-23
Microbot Medical Inc. Announces Special One-Time Cash Bonuses and Amended Compensation for Executives and Non-Management Board Members

Introduction

Company Name.
Microbot Medical Inc
Affiliated Markets:
NASDAQ
Listing Date:
--
Main Business:
Microbot Medical Inc., a pre-clinical medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company offers LIBERTY, a disposable robotic system for use in endovascular interventional procedures, such as cardiovascular, peripheral, and neurovascular; NovaCross, an intraluminal revascularization device; ViRob, an autonomous crawling micro-robot that cam crawl in various natural spaces within the human body, including blood vessels, the digestive tract and the respiratory system, as well as artificial spaces such as shunts, catheters, ports, etc.; TipCAT, a disposable self-propelled locomotive device for tubular anatomies; and One & Done platform. The company has a strategic collaboration agreement with Stryker Corporation for technology co-development. Microbot Medical Inc. was founded in 2010 and is based in Hingham, Massachusetts.
Issue price:
--